bioAffinity Tech Showcases CyPath Lung Research at CHEST 2025
October 20, 2025
bioAffinity Technologies, Inc., a biotech firm focused on developing noninvasive diagnostic tools for lung cancer and other pulmonary conditions, has announced its participation at CHEST